Cargando…

Adalimumab Induced or Provoked MS in Patient with Autoimmune Uveitis: A Case Report and Review of the Literature

Anti-tumor necrosis factor α (anti-TNF-α) agents have been widely used in the field of autoimmune diseases and have proved decisive efficacy and relative safety. Data concerning their adverse effects has been lately describing central nervous system (CNS) demyelination process at escalating basis. C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alnasser Alsukhni, Rana, Jriekh, Ziena, Aboras, Yasmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093248/ https://www.ncbi.nlm.nih.gov/pubmed/27840642 http://dx.doi.org/10.1155/2016/1423131

Ejemplares similares

LETM presented with causalgia and ensued by sudden death
por: Alsukhni, Rana Alnasser, et al.
Publicado: (2017)

Delirium as presenting symptom of neuro-Behcet’s disease
por: Alnasser Alsukhni, Rana, et al.
Publicado: (2016)

Status epilepticus following local anesthesia in a previously healthy adult
por: Alsukhni, Rana Alnasser, et al.
Publicado: (2016)

Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis
por: Mase, Oliver, et al.
Publicado: (2023)

Pure Autonomic Failure-A Localized Alpha Synucleinopathy with a Potential for Conversion to More Extensive Alpha Synucleinopathies
por: Bhattacharjee, Shakya, et al.
Publicado: (2022)

Profile of adalimumab and its potential in the treatment of uveitis
por: Balevic, Stephen J, et al.
Publicado: (2016)

Adalimumab in Treatment of Uveitis in Pediatric Behcet’s Disease–a Case Report
por: Halilbasic, Meliha, et al.
Publicado: (2021)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Outcome of adalimumab monotherapy in paediatric non-infectious uveitis
por: Al-Julandani, DA, et al.
Publicado: (2023)

Factors Correlated with Unfavorable Outcome after Carpal Tunnel Release Surgery
por: Fakhouri, Fakhr, et al.
Publicado: (2017)

Adalimumab-Induced Lupus Nephritis: Case Report and Review of the Literature
por: Kazzi, Brigitte, et al.
Publicado: (2022)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Effectiveness of adalimumab in the treatment of juvenile idiopathic arthritis associated with uveitis
por: Zholobova, Elena, et al.
Publicado: (2014)

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
por: Hiyama, Tomona, et al.
Publicado: (2019)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
por: Lanz, Sofia, et al.
Publicado: (2021)

Uveitis and autoimmune hepatitis, a real entity? A case report with review of the literature
por: Alshahrani, Saeed, et al.
Publicado: (2021)

Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
por: Vougiouka, O, et al.
Publicado: (2011)

Uveitis Occurring in a Patient with Psoriasis during Adalimumab Therapy: A Case Report
por: Zheng, Qiaoli, et al.
Publicado: (2022)

Pulmonary Sarcoidosis Induced by Adalimumab: A Case Report and Literature Review
por: Sim, Jae Kyeom, et al.
Publicado: (2016)

Adalimumab-Induced Lupus Serositis: A Case Report and Review of the Literature
por: Lee, Sandy, et al.
Publicado: (2023)

Review of Systemic Immunosuppression for Autoimmune Uveitis
por: Castiblanco, Claudia, et al.
Publicado: (2014)

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis
por: Erckens, R. J., et al.
Publicado: (2011)

Usefulness of Adalimumab in the Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
por: García-De-Vicuña, Carmen, et al.
Publicado: (2013)

Adalimumab in patients with vision-threatening uveitis: real-world clinical experience
por: Tang Lee Say, Timothy Lee, et al.
Publicado: (2021)

Microbiome and Autoimmune Uveitis
por: Horai, Reiko, et al.
Publicado: (2019)

Certolizumab-Induced Uveitis: A Case Report and Review of the Literature
por: Moisseiev, Elad, et al.
Publicado: (2014)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2013)

Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review
por: Ming, Shuai, et al.
Publicado: (2018)

Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis
por: Liu, Weishai, et al.
Publicado: (2023)

Using Adalimumab to Treat Autoimmune Enteropathy
por: Trivedi, Hirsh D., et al.
Publicado: (2019)

Comment on the Article “Adalimumab-Induced Lupus Nephritis: Case Report and Review of the Literature”
por: Drosos, Alexandros A., et al.
Publicado: (2023)

Adalimumab-induced systemic lupus erythematosus: A case report and review of the literature
por: Landells, Fiona M, et al.
Publicado: (2023)

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
por: Joos, R, et al.
Publicado: (2011)

Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis
por: Kotaniemi, Kaisu, et al.
Publicado: (2011)

Quiescence and Subsequent Anterior Chamber Inflammation in Adalimumab-treated Pediatric Noninfectious Uveitis
por: Choe, Sooyeon, et al.
Publicado: (2020)

Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
por: Sota, Jurgen, et al.
Publicado: (2021)

Clinical benefits and potential risks of adalimumab in non‐JIA chronic paediatric uveitis
por: Kouwenberg, Carlyn V., et al.
Publicado: (2021)

Modifier loci condition autoimmunity provoked by Aire deficiency
por: Jiang, Wenyu, et al.
Publicado: (2005)

Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
por: Acharya, Nisha R., et al.
Publicado: (2020)

Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry
por: Vitale, Antonio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_07v3b5b5nvjuhku1g4kbcd7jse